Your browser doesn't support javascript.
loading
Establishment of a novel NFAT-GFP reporter platform useful for the functional avidity maturation of HLA class II-restricted TCRs.
Fujiki, Fumihiro; Morimoto, Soyoko; Nishida, Yuya; Tanii, Satoe; Aoyama, Nao; Inatome, Miki; Inoue, Kento; Katsuhara, Akiko; Nakajima, Hiroko; Nakata, Jun; Nishida, Sumiyuki; Tsuboi, Akihiro; Oka, Yoshihiro; Oji, Yusuke; Sogo, Shinji; Sugiyama, Haruo.
Affiliation
  • Fujiki F; Department of Cancer Immunology, Osaka University Graduate School of Medicine, Suita, Osaka, 565-0871, Japan. fu-fuji@sahs.med.osaka-u.ac.jp.
  • Morimoto S; Department of Cancer Immunotherapy, Osaka University Graduate School of Medicine, Suita, Osaka, 565-0871, Japan. fu-fuji@sahs.med.osaka-u.ac.jp.
  • Nishida Y; Department of Cancer Stem Cell Biology, Osaka University Graduate School of Medicine, Suita, Japan.
  • Tanii S; Department of Clinical Laboratory and Biomedical Sciences, Osaka University Graduate School of Medicine, Suita, Japan.
  • Aoyama N; Department of Functional Diagnostic Science, Osaka University Graduate School of Medicine, Suita, Japan.
  • Inatome M; Department of Functional Diagnostic Science, Osaka University Graduate School of Medicine, Suita, Japan.
  • Inoue K; Department of Functional Diagnostic Science, Osaka University Graduate School of Medicine, Suita, Japan.
  • Katsuhara A; Department of Clinical Laboratory and Biomedical Sciences, Osaka University Graduate School of Medicine, Suita, Japan.
  • Nakajima H; Department of Functional Diagnostic Science, Osaka University Graduate School of Medicine, Suita, Japan.
  • Nakata J; Department of Cancer Immunology, Osaka University Graduate School of Medicine, Suita, Osaka, 565-0871, Japan.
  • Nishida S; Department of Clinical Laboratory and Biomedical Sciences, Osaka University Graduate School of Medicine, Suita, Japan.
  • Tsuboi A; Strategic Global Partnership & X (Cross)-Innovation Initiative, Graduate School of Medicine, Osaka University & Osaka University Hospital, Suita, Japan.
  • Oka Y; Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita, Japan.
  • Oji Y; Department of Cancer Immunotherapy, Osaka University Graduate School of Medicine, Suita, Osaka, 565-0871, Japan.
  • Sogo S; Department of Cancer Stem Cell Biology, Osaka University Graduate School of Medicine, Suita, Japan.
  • Sugiyama H; Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita, Japan.
Cancer Immunol Immunother ; 72(7): 2347-2356, 2023 Jul.
Article in En | MEDLINE | ID: mdl-36939853
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunotherapy, Adoptive / Neoplasms Limits: Humans Language: En Journal: Cancer Immunol Immunother Journal subject: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Year: 2023 Type: Article Affiliation country: Japan
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunotherapy, Adoptive / Neoplasms Limits: Humans Language: En Journal: Cancer Immunol Immunother Journal subject: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Year: 2023 Type: Article Affiliation country: Japan